Roche Loses Bid To Block Generic Boniva
Pharmaceutical giant Hoffmann-La Roche Inc. lost a bid Wednesday to block Apotex Inc., Mylan Inc. and other generic-drug makers from releasing a version of the osteoporosis drug Boniva after a judge...To view the full article, register now.
Already a subscriber? Click here to view full article